Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 221

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 1B
Chunk 221
---
 standard as of December 31, 2024, which adoption only impacted the Company's segment reporting disclosures (see Note 13 for further information).

 F-12

3. Balance Sheet DetailsPrepaid Expenses and Other Current AssetsPrepaid expenses and other current assets consisted of the following: 

        December 31,2024

        December 31,2023

        Prepaid insurance costs
         
        $
        17,198

        $
        55,215

        Other prepaid expenses & current assets

        49,501

        29,476

        Total prepaid expenses & current assets
         
        $
        66,699

        $
        84,691

       Property and Equipment, NetProperty and equipment, net consisted of the following: 

        December 31,2024

        December 31,2023

        Lab equipment
         
        $
        151,134

        $
        131,963

        Total property and equipment, gross

        151,134

        131,963

        Accumulated depreciation

        (94,802
        )

        (66,879
        )

        Total property and equipment, net
         
        $
        56,332

        $
        65,084

       Depreciation expense was $27,923 for year ended December 31, 2024 and $25,049 for the year ended December 31, 2023. Accrued ExpensesAccrued expenses consisted of the following: 

        December 31,2024

        December 31,2023

        Accrued payroll and related expenses
         
        $
        835,724

        $
        768,720

        Accrued clinical study expenses

        183,824

        10,268

        Accrued professional fees

        67,049

        219,888

        Accrued clinical development costs

        41,203

        153,584

        Total accrued expenses
         
        $
        1,127,800

        $
        1,152,460

 F-13

4. Commitments and ContingenciesLease CommitmentsThe Company leases 2,140 square feet of laboratory space located at 11011 Torreyana Road, Suite 102, San Diego, California (the “Lease”). In December 2024,